Current Drug Targets


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer

TNF-α and IL-6: The Link between Immune and Bone System

Volume:21   Issue: 3
Pp: 213-227
Tiantian Wang and Chengqi He*
DOI: 10.2174/1389450120666190821161259

Nanosized Modification Strategies for Improving the Antitumor Efficacy of MEK Inhibitors

Volume:21   Issue: 3
Pp: 228-251
Yanan Li, Qingrong Dong, Ting Mei, Meichen Zheng, Ramasamy Raj Kumar, Bin Yu, Chunsheng Wu, Hui Zhang* and Feifei An*
DOI: 10.2174/1389450120666190807143245

Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer

Volume:21   Issue: 3
Pp: 258-278
Ashish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, Ira Skvortsova and Vinod Kumar*
DOI: 10.2174/1389450120666190821160730

Urea Transporters Identified as Novel Diuretic Drug Targets

Volume:21   Issue: 3
Pp: 279-287
Min Li, Shun Zhang and Baoxue Yang*
DOI: 10.2174/1389450120666191129101915

The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy

Volume:21   Issue: 3
Pp: 288-301
Lin Zhou, Luyao Ao, Yunyi Yan, Wanting Li, Anqi Ye, Yahui Hu*, Weirong Fang* and Yunman Li*
DOI: 10.2174/1389450120666190906153652

Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014

Volume:21   Issue: 3
Pp: 302-317
Yan Xiao and Yajun Liu*
DOI: 10.2174/1389450120666190829162544